Tipping the balance: a biased nanobody antagonist of CCR3 with potential for the treatment of eosinophilic inflammation
File(s)JACI Accepted.pdf (91.78 KB)
Accepted version
Author(s)
Pease, James E
Williams, Timothy J
Type
Journal Article
Date Issued
2018-11-17
Date Acceptance
2018-10-23
Citation
Journal of Allergy and Clinical Immunology, 2018, 143 (2), pp.552-553
ISSN
0091-6749
Publisher
Elsevier
Start Page
552
End Page
553
Journal / Book Title
Journal of Allergy and Clinical Immunology
Volume
143
Issue
2
Copyright Statement
© 2018 American Academy of Allergy, Asthma & Immunology. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence http://creativecommons.org/licenses/by-nc-nd/4.0/
Sponsor
Medical Research Council (MRC)
Medical Research Council (MRC)
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/30452926
PII: S0091-6749(18)31603-8
Grant Number
G1000758
G1000758
Subjects
Allergic inflammation
CCR3
asthma
biased antagonist
eosinophil
inflammation
Publication Status
Published
Coverage Spatial
United States
Date Publish Online
2018-11-17